InsidersTradesSigma
Follow the NIKA PHARMACEUTICALS, INC share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €534.8m. The latest transaction was reported on 19 March 2025 (Cession). Among the most active insiders: NIKA PHARMACEUTICALS, INC. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
NIKA PHARMACEUTICALS, INC is a company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker XNAS.